Posted on Leave a comment

Top Tips When Talking to a Healthcare Provider

daughter explaining elderly mother how using smartphone

Because of lockdowns prompted by the global health crisis, many people still fear visiting hospitals and even private clinics in person. Talking to a healthcare provider is a great way to avoid pandemic-related risk without sacrificing your access to proper healthcare.

Written exclusively for by Aria Covers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

By getting in touch with a healthcare provider, you can get essential medical prescriptions, specific instructions on treating particular conditions, and even practical information on new treatments for COVID-19 patients. Today, the field of telehealth has expanded to include not just home health monitoring devices, but also efficient online communication platforms that make remote diagnosis possible. What can you do to streamline your communication with your healthcare provider when contacting them online?

Get in touch with and get to know the right specialists

Make sure you’re contacting the right people for the job. This will allow you to arrive at a safe and correct medical solution faster. Rather than getting transferred from call-to-call or email-to-email, actively finding the best specialist who can answer your specific inquiries makes the entire process quicker and more convenient for everyone involved. This is particularly crucial in the modern pandemic era, in which there is a massive shortage of health workers, particularly nurses.

Nurses are not only the backbone of the front-line efforts against COVID, they’re also likely to be the first qualified specialists you will be put in touch with by healthcare providers. This demand is why the nursing profession is expected to grow by 7% until 2029. Unfortunately, the bachelor’s and graduate degree programs from brick-and-mortar nursing schools and universities are currently unable to accommodate new students to respond to the demand. But the good news is that the digital migration of education is allowing both traditional and online universities to pick up the slack. In fact, current online RN to BSN degree programs which allow registered nurses to train for in-demand specializations can now be taken and completed 100% through remote work. So if you are looking for specialist advice and get through to a nurse know that they will be fully qualified to answer your concerns and questions. Just note that when you do manage to contact the right specialist, it’s important to remember that their time may be limited, as the shortage has stretched practically all nurses and other health providers thin. This brings us to our next point.

Ask informed questions

You can always turn to Google to find fundamental and objective information on practically any medical or health-related concern or inquiry. Doing this is a good way to further streamline the online consultation process. By coming to an online discussion with your healthcare provider from an informed perspective, they can more efficiently provide you with the right solutions, treatments, prescriptions, or plans. While speaking directly with a healthcare provider is still much safer than scrounging the web for info, a little online research definitely helps. There’s also a variety of legitimate sources of medical information that can be found on the web today. The Centers for Disease Control and Prevention for instance has been quite active at updating its online portal for any questions that people might have about the COVID-19 vaccine. The better you can ask informed questions, the faster you can get useful answers.

Be honest, straightforward, and upfront

If there’s anyone that you should be honest and straightforward with, it’s your healthcare provider. For instance, the more you can tell us about your condition and any related concerns, the better we at D’oxyva can develop your online personalized recovery-oriented program or plan. Having a full and upfront purview of your medical history gives healthcare providers everything they need to provide adequate solutions.

In the era of telehealth, it’s easier than ever to talk to healthcare providers. And by following these aforementioned tips, you can maximize your limited time online with these nurses, doctors, therapists, and other specialists.

physician-recommended, easy to use daily

Why Use D'OXYVA?

Experts say D’OXYVA® can help patients find relief. Overwhelming  medical data shows people with preexisting conditions, including diabetes may experience serious complications with COVID-19.

D’OXYVA significantly helps people and their pets by gently and quickly spraying a patented and patent-pending ultra-purified, supersaturated solution on the skin surface to achieve major health benefits for well over 90% of users.

Experts call D’OXYVA a game-changer biotech. “Studies with D’OXYVA have shown unmatched results in noninvasive wound care,” Dr. Michael McGlamry. Anyone with an underlying condition should know this option is available.

Reduce unwanted doctor visits, recommended and ranked top by experts!

Posted on Leave a comment

While coronavirus vaccines race ahead, our treatment options remain mediocre. There are good reasons for that.


Just a year into the pandemic, three vaccines have already been found to protect people from coronavirus infection – the fastest vaccine development process in history by at least four years. The US public will likely start getting shots within weeks. In the last month, Pfizer Moderna, and AstraZeneca have all announced that their coronavirus vaccine candidates were found to be effective in trials.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
Meanwhile, none of the drugs we have for COVID-19 so far are particularly effective.Experts cite several reasons why: Vaccines have received far more funding due to their potential to stop the pandemic, and they’re easier to test in large studies.Yet for people who get sick, treatment options are still far from perfect.The Food and Drug Administration has approved one coronavirus treatment and authorized five others. But for severely ill patients, only one therapy – steroids – has been found to definitively reduce death rates.The therapies authorized for less-serious COVID-19 cases, meanwhile, all belong to the same family: monoclonal antibodies. While promising, these treatments are expensive, difficult to manufacture, and haven’t yet demonstrated efficacy in large trials.There are several reasons our vaccine options have outstripped treatments. The first is cost-effectiveness: While vaccines are expensive and time-consuming to develop, they have the potential to stop the pandemic. Treatments only help those already sick, so are less valuable to governments overall.“I’m not surprised that there’s been more aggressive funding to work with vaccines, because I think, in the end, that’s how we’re going to turn the tide on this,” Taison Bell, an infectious-disease physician at the University of Virginia, told Business Insider.

text: A vial of remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020. Ulrich Perrey/Reuters

Additionally, researchers can conduct vaccine trials on tens of thousands of healthy volunteers, whereas studies about treatments require thousands of sick patients.

And finally, treatments are notoriously difficult to develop for viruses, especially respiratory ones. Scientists have been trying, and failing, to find effective treatments for rhinoviruses – which cause most common colds – since the 1950s.

The juxtaposition was stark: In the same mid-November week, Moderna announced that its vaccine was found to be 94.5% effective, and the World Health Organization announced that it won’t recommend the antiviral drug remdesivir, since it hasn’t been found to lower mortality rates.

Remdesivir is the only coronavirus treatment the FDA has formally approved. Although some studies show it can shorten hospital stays for seriously ill patients, it doesn’t appear to reduce the incidence of death. It’s also expensive, at $2,340 for a standard course.

The FDA has granted emergency authorization to six other coronavirus treatments, including convalescent plasma, corticosteroids, and hydroxychloroquine, though the agency then revoked hydroxychloroquine’s authorization in June.

The most recent drug to get FDA authorization, the monoclonal antibody therapy bamlanivimab, targets the coronavirus’ spike protein to block its entry into cells. But the treatment does not appear to benefit hospitalized patients, according to studies.

“These are sort of things that move the bar a little bit, but none of these are game-changers,” Bell said.

Monoclonal antibody treatments are also hard to manufacture and distribute, according to Bell: They can take up to two weeks to produce in a complex process that can require 10 distinct steps.

Corticosteroids, meanwhile, can lower death rates, and they’re cheap: A standard treatment course of the steroid dexamethasone will likely cost between $10 and $13, according to Michael Rea, the CEO of Rx Savings Solutions. But steroids can have damaging side effects and even make patients vulnerable to other infections, which is why they’re only authorized for patients with severe COVID-19.

a hand holding a blue and white shirt: The world’s eyes are trained on the few companies coming forward with vaccines for coronavirus, but with companies like Pfizer and Moderna getting very close to releasing theirs to the public, and others like Johnson & Johnson’s being paused due to an unexplained illness just when it was starting to gain traction, the question mark around people’s trust in vaccines continues to grow.Besides the conspiracy theories that companies are trying to put chips in humans, or the repeatedly disproved theories that vaccines cause autism, people are concerned about the speed with which these new vaccines are being created, and much of the fear around them comes from not fully understanding how they work. And that goes for vaccines of all sorts!So, click through to read about how regular vaccines work, how COVID-19 vaccines are developing, and what the new RNA technology means for our immunization and the (hopeful) end of this pandemic.

Viruses are hard to treat

Viruses are simply more difficult to target with medications than other illnesses, Bell said.

“Viruses, for the most part, operate inside of our body’s cells, which is much harder to target than, say, bacteria, where most live outside of our body cells and are more readily attacked by antibiotics,” he explained.

Plus, studies of new treatments generally require large numbers of sick patients, whereas vaccine studies can just give shots to healthy volunteers then see who gets sick. Most treatment studies are also messier, since many patients in hospitals often get combinations of different therapies.

Albert Rizzo, chief medical officer for the American Lung Association, said that although it’s unfortunate so many people have gotten COVID-19, the sheer number of patients has accelerated medical researchers’ ability to figure out how best to help people.

“Right now, the medical industry, or healthcare system, has learned a lot more about how to treat patients,” he told Business Insider.

Doctors have learned to avoid ventilators when possible, monitor blood-oxygen levels of high-risk patients, and administer treatments when they’re most effective in the course of an illness, he explained.

a person standing in front of a building: Medical staff wearing full PPE push a stretcher with a deceased patient to a car outside of the COVID-19 intensive care unit at the United Memorial Medical Center on June 30, 2020 in Houston, Texas. Go Nakamura/Getty Images

Vaccines spur the body to annihilate viruses

Vaccines train the body’s own immune system to kill a virus before it can enter too many cells.

Pfizer and Moderna’s vaccines are each than 94% effective, and AstraZeneca’s candidate seems to be 70% effective, on average. Pfizer plans to send out 6.4 million doses of its vaccine within 24 hours of getting regulatory clearance, which could happen by mid-December. Moderna expects to have between 100 and 125 million doses ready in the first quarter of 2021, and 20 million doses in the US by the end of the year.

All three vaccine candidates got some degree of financial backing from Operation Warp Speed, which aims to produce and distribute 300 million vaccine doses in the US by January. The program has awarded more than $12 billion in contracts to spur the rapid development and testing of eight primary vaccine candidates.

But it has only funded three treatments, all of them monoclonal antibodies.

Capped vials used during filling and packaging tests for the large-scale production of AstraZeneca and the University of Oxford's COVID-19 vaccine candidate. VINCENZO PINTO/AFP via Getty Images

Vaccines offer ‘the most benefit for the dollar spent’

The dizzying speed of coronavirus vaccine development is not cause for alarm, according to Rizzo.

“We’re not skipping steps – we actually have better technology,” he said, citing advances in genetic sequencing and mRNA technology. “It’s like saying, why did it take two weeks to cross the Atlantic back in the 1800s? Well, we had to go on a boat. Whereas now you can get across the ocean in several hours.”

Given that, experts say, drugs simply deliver less value than vaccines.

“If I was controlling funding and trying to divert the resources where I think I would get the most benefit for the dollar spent, I would actually develop it towards vaccines,” Bell said.

Rizzo said he is looking forward to more research on several other possible therapies, though. One, infliximab, may help keep the immune system from overreacting to coronavirus. A September article in The Lancet Rheumatology suggested the drug could “have a major impact on the need for ventilation and mortality.”

Baricitinib could also be found to significantly reducing mortality for people with serious cases of COVID-19 once larger trials are conducted. A small, early study found that 17% of patients given the drug died or needed a ventilator, compared with 35% in the control group.

Still, researchers haven’t found a drug that’s cheap, easy to distribute, and meaningfully improves outcomes for patients with less severe symptoms.

“All things considered, I’m most happy that we have multiple vaccine candidates at this point,” Bell said.

physician-recommended, easy to use daily

Why Use D'OXYVA?

Experts say D’OXYVA® can help patients find relief. Overwhelming published medical data shows people with preexisting conditions, including diabetes may experience serious complications with COVID-19. D’OXYVA significantly helps people and their pets by gently and quickly spraying a patented and patent-pending ultra-purified, supersaturated solution on the skin surface to achieve major health benefits for well over 90% of users. Experts call D’OXYVA a game-changer biotech.

“Studies with D’OXYVA have shown unmatched results in noninvasive wound care,” Dr. Michael McGlamry. Anyone with an underlying condition should know this option is available.

Reduce unwanted doctor visits, recommended and ranked top by experts!

Posted on Leave a comment

Children born at high altitudes may be stunted in growth and development, study finds

D'OXYVA for Kids

Children born at 5,000 feet or more above sea level are typically smaller at birth and more likely to remain stunted than those born at lower altitudes, according to new worldwide research published Monday.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
This was true even if the children were born into “ideal-home environments” defined as having good health coverage, higher living conditions and highly educated mothers, the study found, which meant stunting was unlikely to be due to common risk factors such as poor diet and disease.

Growth declined as altitude grew

Children living in ideal home environments grew at rates deemed standard by the World Health Organization until they lived at around 500 meters (1,650 feet) above sea level, the study found. At that altitude and higher, children’s height-for-age scores began to decrease.
At levels of 1,500 meters, or approximately 5,000 feet, above sea level, children were “born at shorter length and remained on a lower growth trajectory” than children who lived in cities at lower sea levels, according to the study published Monday in JAMA Pediatrics.
Prior research has shown growing shorter and slower at higher altitudes can lead to an increased risk of cognitive deficits and metabolic developmental impairments tied to chronic diseases in later life.

A worldwide study

The study looked at height-for-age data for more than 950,000 children in 59 countries.
“More than 800 million people live at 1,500 meters above sea level or higher, with two-thirds of them in Sub-Saharan Africa, and Asia,” said study co-author Kalle Hirvonen, a senior research fellow at the International Food Policy Research Institute, in a statement.
However, there are a number of cities in the United States that fall above 5,000 feet, including Butte, Montana; Cheyenne, Jackson and Laramie, Wyoming; Flagstaff, Arizona; Las Vegas, Albuquerque and Santa Fe, New Mexico; Mammoth Lake, Big Bear Lake and South Lake Tahoe in California; and about 37 cities in Colorado, among others.
In fact, Aspen, Breckenridge and Telluride in Colorado and Santa Fe in New Mexico are all above 7,000 feet above sea level.

Pregnancy highest risk

The study found most of the risk was in the period leading up to and immediately after birth and may be due to lower oxygen levels at higher altitudes.
“Pregnancies at high-altitudes are characterized by chronic hypoxia, or an inadequate supply of oxygen, which is consistently associated with a higher risk of fetal growth restriction,” Hirvonen said.
It was thought that genetic adaption to residing at high altitude over multiple generations might mitigate the stunting, but the study did not show that, Hirvonen said.

“After birth, the growth curve for children in areas 1,500 (meters) or more above sea level was consistently lower, implying limited catch-up to growth levels of children residing in areas lower than 1,500 (meters) above sea level,” the study found.
The results should educate health professionals to more closely work with pregnant women to control the effects of high altitude on the fetus, the study authors said.
“A first step is to unravel the complex relationship linking altitude, hypoxia and fetal growth to identify effective interventions,” said study co-author Kaleab Baye director of the Center for Food Science and Nutrition in Addis Ababa, Ethiopia.
“If children living at altitude are, on average, more stunted than their peers at sea level, then a more significant effort to address high altitude stunting is needed,” Hirvonen said.

physician-recommended easy to use daily

Why Use D'OXYVA?

D’OXYVA® (deoxyhemoglobin vasodilator) is an over-the-counter (OTC) device, which is the first biotech solution of its kind backed by widely-established groundbreaking Nobel Prize-winning science validated to significantly improve macro-, and micro-circulation of blood flow and certain nerve activities in the body such as the autonomic nervous system, which together are widely reported to form an effective solution option for many of the most severe and widespread health conditions.

D’OXYVA has proven itself especially effective for the most at-risk and complex cases in over three dozen human studies during its nearly decade-long clinical research and real-life results in over two dozen countries.

D’OXYVA’s eight years of comprehensive clinical research conducted by the world’s foremost medical experts has demonstrated massive improvements for the autonomic nervous system, heart rate variability, and oxygen-rich blood flow in many parts of the body for patients with a variety of neurological symptoms as well as other discomforts. No major adverse or negative effects have ever been reported about D’OXYVA as of today.

Reduce unwanted doctor visits, recommended and ranked top by experts!

Posted on Leave a comment

Top 5 New Innovations in Health Care Technology To Watch Out On 2020

health technology innovation

The following are the top 5 new innovations in health care technology, some of which aided in the early lung cancer diagnosis of Amos B, a 58-year-old man who had been coughing up blood for 2 months. Amos was also experiencing loss of appetite, hoarseness, wheezing, and shortness of breath; he had smoked 2 packs of non-filtered cigarettes daily since he was 15 years old. 

Share It

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

Amos’ early lung cancer was diagnosed using artificial intelligence for the analysis of his lung CT and of lung biopsy samples. He received early treatment and recovered completely.

#1 – Artificial Intelligence for Use in the Pathological Diagnosis of Lung Cancer

Artificial intelligence (AI) refers to the performance of tasks by computers that normally would require the input of human intelligence.

Using AI, specialized pathology computer programs are able to diagnose lung cancer based on the recognition of abnormalities found on slides of pathological specimens of lung tissue[1].

To accomplish this, a computer program was programmed to read hundreds of pathological slides of lung tissue and recognize various forms of lung cancer with an accuracy rate even higher than that of pathologists.

#2 – 3D Printing for Use in Total Knee Replacements

Image result for 3D Printing for Use in Total Knee Replacements

3D printers, which were first developed in 1983, make 3-dimensional objects by laying down successive layers of material following a computer-aided design (CAD).

This specialized software uses the specific measurements of CT scans of the knee, hip, and ankle to make an exact 3D model of a patient’s knee.

When a knee replacement is produced by 3D printing, the layers of the knee replacement consist of ABS plastic, resin, stainless steel, gold, silver, titanium, ceramic, and gypsum.

This process has been used in over 100,000 complete knee replacements during 2019.

3D-printed knee replacement results in shorter hospital stays, decreased recovery times, decreased post-operative pain, increased post-operative range of motion, and a better overall custom fit.[2]

#3 – Shravya Shetty: Artificial Intelligence Used to Diagnose Lung Cancer by Chest CT

Shravya Shetty[3], the head researcher of a Google Health Team, has developed an artificial intelligence algorithm to accurately diagnose lung cancer by analyzing chest CT scans.

The AI algorithm follows a set of commands (algorithms) to analyze the chest CT and even “learns” as it reviews CT scans.

After being trained with 45,000 lung cancer patients’ chest CT scans fed into an AI program, the AI program picked up 5% more cases of lung cancer then a team of 6 board-certified radiologists.

It also had 11% fewer false positive readings.

#4 – Semma Therapeutics Implantable Device for Insulin Delivery

Semma Therapeutics[4], recently acquired by Vertex Pharmaceuticals, is in the process of developing an implantable device for type 1 diabetes (which occurs due to an autoimmune response that attacks the insulin-producing beta cells of the pancreas).

This implantable device contains a supply of pancreatic islet cells derived from high-quality human pluripotent stem cells.

These stem-cell derived pancreatic cells have been found to produce almost normal levels of insulin and successfully lower blood sugar levels.

The insulin is released through the membrane of the device, which is permeable to insulin and glucose but not to immune cells.

This keeps immune cells out of the device, thus avoiding immune reactions such as organ rejection.

#5 – D’OXYVA Deoxyhemoglobin Peripheral Vasodilator

D’OXYVA[5] is an innovative, painless, non-invasive, deoxyhemoglobin vasodilator application that works by applying a transdermal vapor of CO2 and water through the skin of the thumb over a 5-minute period.

The CO2 then travels to the microcirculation system (smallest blood vessels in the body: arterioles, venules, and capillaries), where it stimulates vasodilation.

This vasodilation of the microcirculation system increases the amount of oxygen and nutrients delivered to the tissues, which results in various healing effects.

D’OXYVA, which is produced by Circularity Healthcare, has been used with great application success in non-healing diabetic foot ulcers, chronic wounds, chronic pain, depression, poor athletic performance, cardiovascular rehabilitation, migraine headaches, diabetic neuropathy, varicose and spider veins, and other conditions.


D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Innovative Collaboration: The Cutting Edge of Medicine Goes “Behind The Scenes”

D'OXYVA | Cardiovascular, Diabetes Care, Pain Reliever in California


Circularity is partnering with Telly Award-Winning “Behind the Scenes” to provide regular, ongoing, high-quality content from leading experts in a variety of fields with an initial focus on microcirculation science, regenerative medicine, and advanced wound healing and related symptoms. The show reaches 60 million households domestically.

“Behind The Scenes with Host Laurence Fishburne” is a public television icon that has won numerous awards and delivers precision idea-telling at its best. Circularity is an innovative healthcare organization that is health-bent on their trademarked slogan: “Improving Lives by Improving Blood Flow.” Their coming together to bring forward the ideas of modern health science on a stellar entertainment platform can only make for riveting content going forward. Viewers will find themselves in a win-win situation.

Watching informative content via this stylized venue will leave viewers feeling quite satisfied with their television watching experience. It is time well spent and information precisely delivered.

A Little More About Circularity

Circularity is concerned with bringing the very best in Health care innovation to the public. In so doing, they have manufactured a product called D’OXYVA. This product has a two-pronged approach to health. First, it can be quite effective in reducing the debilitative effects of many of the diseases that are affecting the world today, such as COPD, diabetes, and cardiovascular illnesses. Secondly, Circularity’s D’OXYVA can be used in a preventative capacity to improve microcirculation. The concept of microcirculation has far-reaching implications in neurology, oncology, endocrinology, cardiovascular health, respiratory health, dermatology, diabetic wound healing or diabetic wound care and other major fields.

What “Behind The Scenes with Host Laurence Fishburne” Will Bring to the Table

Behind The Scenes has been an innovator in bringing information to the forefront in the public television space. The award-winning series features segments on the newest technologies, as well as fresh takes on existing entities, phenomenon, and natural occurrences. The show’s website boasts that the television series “highlights the evolution of education, medicine, science, technology and industry through inspiring stories.”

Aside from the Emmy-winning and Academy Award nominated actor Lawrence Fishburne as host, the program has an award-winning creative development team. Viewers walk away with a rich knowledge of the subject. Viewers may have known about this subject their whole lives, or it may be about something completely new. Viewers learn an evolving aspect of the topic which keeps the perspective fresh.

The dawning of a new age has appeared with this collaboration. Individuals who want to know more about what the health science field is bringing into our hospitals and doctors’ offices will not be disappointed. In today’s world, it is imperative that we are advocates for our own health.

Coming Soon: Miami ReLife’s Dr. Steven Gelbard

The first series is with Dr. Steven Gelbard, a nationally-famed authority with his ReLife Miami Institute on stem cells. Dr. Gelbard presents D’OXYVA’s Nobel Prize-winning science as a regenerative medicine. Dr. Gelbard is involving his direct contacts with top NFL players and other top sports celebrities in the monthly series, along with 25—40 top neurosurgeons and other experts working under ReLife.

Imagine having the ability to receive D’OXYVA and other innovative treatments and non-invasive procedures for chronic wound care amid the luxury of a five-star hotel. Behind The Scenes guest, Dr. Gelbard, a Tufts School of Medicine educated neurosurgeon, makes it happen right now. Medicine has left the hospital building and has become the proactive choice of the health conscious. We can all look forward to learning more about how to live a healthier and more informed lifestyle from this awe-inspiring episode.

According to Norbert Kiss, President and CEO of Circularity Healthcare, this collaboration is door busting. Mr. Kiss tells us, ”[We] can offer unprecedented access to this amazing Emmy-winning show called Behind the Scenes with very amazing terms due to our strategic involvement. We welcome any expert.”

Laurence Fishburne, host of Behind The Scenes,” beckons, “Join me as we all discover the endless ways to enjoy the skills and imagination.”

Don’t miss the evolution. It’s being televised. Circularity and Behind The Scenes—Stay tuned for a mind-fortifying experience!

Circularity Values:

We, at Circularity believe in a long-sought-after goal in health care; people should have access to one health application that solves most of their short and long term health issues without compromising other aspects of their health while doing this quickly, affordably, and without pain.
Circularity develops, manufactures and markets advanced technologies that significantly improve quality of life by improving some of the most essential physiological functions in the body.

About Behind The Scenes With Laurence Fishburne

Behind The Scenes is an award-winning program that highlights new stories and innovative concepts through groundbreaking short-form and long-form documentary presentation. The program, which is anchored by a veteran production team with decades of industry experience, is able to effectively communicate the most critical stories to a wide and diverse audience.

Behind The Scenes with Laurence Fishburne, has established an impressive and heralded career, amassing over one-hundred credits across the varied platforms of stage, television and film. He’s well known for major for roles in such films as; John Wick 2, Fantastic 4 Rise of the Silver Surfer, Mission Impossible III, Mystic River, Boyz n the Hood, What’s Love Got to Do With It, and Apocalypse Now. On the small screen, the award-winning and versatile actor played compelling roles in shows such as CSI: Crime Scene Investigation, CSI: Miami, CSI: New York and Hannibal. The Behind The Scenes Actor currently stars as Pops on the hit TV comedy Black-ish.

About Circularity Healthcare, LLC

Circularity Healthcare, LLC, located in Los Angeles, CA is a private biotech and MedTech products and services company that designs, makes, markets, sells, distributes and licenses its own patented and patent pending technologies, such as its flagship non-invasive deoxyhemoglobin vasodilator product line, D’OXYVA®. One of the main mechanisms underlying D’OXYVA’s science received the Nobel Prize for Medicine in 2019. Circularity enters into exclusive agreements with manufacturers to launch products and with large and small clinics and hospitals in order to help them enhance their profits and credit profiles with a wide variety of advanced products and services. In addition, Circularity Healthcare assists in the financing of equipment, working capital and also patient financing at industry-leading terms and speed.

Posted on Leave a comment

Wearable technology named top health and fitness trend for 2020

health and fitness trend for 2020

More Americans are using wearable fitness trackers than ever to monitor their health, a trend the American College of Sports Medicine says is the top fitness trend for 2020, according to a recent survey.

ACSM’s “Worldwide Survey of Fitness Trends for 2020” interviewed over 3,000 health and fitness professionals, all of which said that wearable technology will be the top trend in fitness next year, with millions of Americans already using such technology to monitor their exercises, heart rate, calorie consumption, sleep quality and step count.

“Wearable tech has become ingrained in today’s culture, and the industry shows no signs of slowing down,” said Walter R. Thompson, Ph.D., ACSM Past President and lead author of the survey and associate dean in the College of Education and Human Development at Georgia State University in Atlanta. “Tech advances have made it easier than ever for users to collect important health metrics and work with fitness professionals and health care providers to improve exercise efficiency, develop healthy lifestyles, manage chronic diseases and, ultimately, increase quality of life.”

This year, ACSM published a new article alongside the survey, “Regional Comparisons: The Worldwide Survey of Fitness Trends,” which compared the top 20 fitness and health-related trends in North America, South America, Europe and China in an effort to gain a better understanding of global developments throughout different regions worldwide. The same methodology was used by ACSM’s “Worldwide Survey of Fitness Trends” in tracking these global trends.

“Through the regional comparison we hope to enhance the scope, reach and relevance of the ACSM fitness trends survey to truly make it an international collaboration,” said Vanessa M. Kercher, Ph.D., M.Ed., co-author of the regional comparison article and a clinical assistant professor in the school of public health at Indiana University. “We plan to continue developing our international partnerships with the goal of improving and expanding the implementation and methodology of the ACSM fitness trends survey. By doing so, we aim to identify fitness trends specific to different international regions so we can explore and communicate regional similarities and differences to readers.”

Wearable fitness devices are expected to evolve quite a bit in the coming years, with Apple patenting  “smart clothes” technology last year that can measure heart rate, blood sugar levels, blood pressure, electrocardiograms, blood oxygen levels and respiration rates all through sensors woven into clothing fabric.


Is your wearable really fitness technology or just more of a fad? If your wearable records heart rate, blood pressure, blood sugar, blood flow (perfusion index), blood oxygen (SpO2), blood pH, we challenge you to prove that you have the best wearable by testing its efficiency with D’OXYVA.

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

Results of improved blood flow (perfusion index) is visible in just after 5 minutes of D’OXYVA therapy and on its highest just after 30 minutes!

Are you up for the challenge? Register below to get further details! Amazing prizes await!

Posted on Leave a comment

Trump Ready To Force Transparency In Healthcare Pricing With An Executive Order

D'OXYVA | Cardiovascular, Diabetes Care, Pain Reliever in CA.

The Trump Administration wants to make it easier for patients and employers to comparison shop for healthcare. On transparency, one can’t fault the Administration for not trying.

So far, the measures implemented have mostly been baby steps. But, this is about to change as President Trump is expected to soon release an executive order on healthcare price transparency. If enacted, this executive order would mandate disclosure of prices throughout the healthcare industry, and be enforceable by federal agencies. It would provide patients and employers pricing data that reflect the negotiated rates between insurers, hospitals, and physicians.

In the lead-up to this week’s expected announcement on the executive order, the Trump Administration has been gradually chipping away to uncover the murky world of healthcare pricing. For example, in October 2018, President Trump signed two bills into law, the Know the Lowest Price Act and the Patients’ Right to Know Drug Prices Act. These bills removed pharmacy gag clauses, imposed by pharmacy benefit managers, which had prevented pharmacists from proactively telling consumers if their prescription would cost less if they paid for it out-of-pocket rather than using their insurance plan.

And, this month, the Department of Health and Human Services (HHS) announced that direct-to-consumer (DTC) advertisements of prescription drugs on television will soon be required to include price information.

Nonetheless, the pharmacy gag clause bills and requirement to include list price information in DTC advertisements only incrementally address prescription drug price transparency. A much bigger step would be to overhaul the prescription drug rebate system, as proposed by HHS. However, it’s unclear whether and when that will happen.

Ultimately, drug price transparency alone won’t be sufficient to create conditions conducive to a competitive market. It needs to be coupled with dissemination of information on which medications are the most effective for specific conditions or diseases. There have been a number of efforts in the commercial sector to address this issue; MedSavvy, for example, which is a Cambia Health Solutions company. Regence Blue Cross and Blue Shield offers MedSavvy to its customers. The federal government is also supporting initiatives to improve the Patient-Centered Outcomes Research Institute’s publication of usable information on comparative effectiveness to consumers. But it’s been a very slow process with few tangible results thus far.

The Trump Administration has also focused on disseminating information regarding the quality of physician practices that serve Medicare beneficiaries. The Centers for Medicare and Medicaid Services (CMS) established a website called Physician Compare. However, nearly 80% of physicians aren’t included in the website database. Reporting is voluntary, and so there’s selection bias when it comes to the performance data that do appear. Moreover, the website doesn’t include a comparison of fees for physician services.

Beginning January 1st this year, the federal government is requiring every hospital in the U.S. to post lists of prices of services and technologies online. Such lists are known in the industry as “chargemasters” that comprise of prices of thousands of services and products for which a hospital may bill.

But, CMS acknowledges it is not yet enforcing the hospital pricing rule. Furthermore, implementation of the rules has sparked a debate about whether the price lists are creating more confusion than clarity among patients. Services and products are identified in acronyms, abbreviations, billing codes, and medical terminology that most consumers can’t be expected to understand.

Additionally, the chargemaster lists don’t normally reflect actual transaction charges because hospitals and insurers generally negotiate significantly lower prices. And, hospitals and insurers are resisting public disclosure of negotiated prices. This week’s expected announcement of an executive order may make such resistance a moot point.

Most patients don’t comparison shop for medical care. Some might not be in a position to do so. Others may simply balk. Perhaps this is due in large part to patients not being used to comparison shopping, or to the opaque character of pricing in the healthcare system. As more useful information becomes available, perhaps patients will begin to do more comparison shopping. which in turn will lead to a more competitive market.


D’OXYVA is the only affordable, fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

7 Subtle Signs That Prove You’re Not As Healthy As You Think You Are

D'OXYVA | Cardiovascular, Diabetes Care, Pain Reliever in CA.

When you say healthy, it often brings to mind an image of person that exercises all the time and only eats nutritious food while avoiding junk like candy and fast food. However, it actually demands so much more than that. Truth is, being truly healthy means that one should have a sense of “physical, mental, and social wellbeing, and the resources to live a full life.”

Of course, we don’t always think of it that way. In fact, in most cases, eating healthy and pairing it with consistent exercise is more than enough. However, while being classified as “overweight” or “underweight” is an obvious sign of being unhealthy, there are also other not-so-obvious signs — ones that you may be ignoring. And ones that may mean you’re not as healthy as you believe you are. Below are some of them.

  1. Snoring – You may think it’s just an embarrassing act, but it can also indicate that you’re not that healthy. In fact, snoring is linked to a variety of health conditions, including sleep apnea, heart disease, and even stroke.
  2. Constant skin breakouts – Skin breakouts are also a sign of general unhealthiness, and unfortunately, there’s no single cause. However, thanks to face mapping, we can now easily adjust our lifestyle based on where we get breakouts. Chin acne for example, means we have to eat healthier, while forehead acne means we need better sleep and hygiene.
  3. The white of your eyes aren’t as white – This one is more subtle, but basically, if your eyes are a tad yellowish, it indicates that you may have complications in your bile ducts, gall bladder, liver or pancreas. There’s also red eyes, which come from lack of sleep and exhaustion.
  4. Your nails have an odd color and texture – A yellowish color in your nails is believed to be caused by fluid build-up and inadequate circulation in the body.
  5. Being gassy – Excessive gas can be signs of an irritable bowel syndrome, lactose intolerance, and celiac disease.
  6. Constant exhaustion – This one is obvious, but continuous exhaustion means that you may have iron deficiency, too little exercise, and even dehydration.
  7. Your urine doesn’t have a pale color – The color, smell, and density of urine can reveal what’s going on in our body. And in this case, having urine that has a darker color or has a strong scent means that you should probably get yourself checked by a doctor ASAP.


D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

“People are dying”: Diabetics rationing insulin amid rising drug prices

D'OXYVA | Cardiovascular, Diabetes Care, Pain Reliever in CA.

Drug manufacturers were grilled Wednesday about the skyrocketing price of insulin, which has doubled in the last five years and led some patients to ration the life-saving drug. One study finds the underuse of insulin could affect nearly 40 million people with diabetes by 2030.

“Nobody cared or nobody understood that without this next vial of insulin, I wouldn’t live to see another week,” said 28-year-old Kristen Whitney Daniels.

She started rationing her insulin after she was kicked off her parents’ insurance plan two years ago.

“I can’t really explain how isolating and how terrifying it is,” she said.

She’s now a patient at the Yale Diabetes Center, where a recent Journal of American Medical Association study found one in four patients reported “cost-related underuse.” Dr. Kasia Lipska treats patients at the clinic, and was the study’s lead author. She testified on Capitol Hill last week.

  • Woman says her son couldn’t afford his insulin – now he’s dead
  • Eli Lilly rolling out half-price insulin. Diabetics say it’s not enough

“This vial of insulin cost just $21 when it first came on the market in 1996. It now costs $275,” she said.

Some drug makers are already reacting to the outrage. On Wednesday, Sanofi announced it will cut the price of insulin for uninsured patients and those who pay cash to $99 per month. But that doesn’t eliminate advocate concerns.

“People are dying from lack of access to a drug that has been around for almost a century. I think it’s unconscionable,” Lipska said.

Insulin manufacturers told CBS News they’ve taken steps to address prices, including offering free medication to people who quality.


D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

Posted on Leave a comment

Patients are transforming from passive recipients of healthcare services to active participants in their own health

D'OXYVA | Cardiovascular, Diabetes Care, Pain Reliever in CA.
This is a preview of a research report from Business Insider Intelligence, Business Insider’s premium research service. To learn more about Business Insider Intelligence, click here. Current subscribers can read the report here.0201The consumerization of healthcare — a fundamental shift in patients’ preferences, behaviors, and demands around healthcare services — is threatening hospitals’ bottom lines. For the first time, patients are transforming from passive recipients of healthcare services to active participants in their own health. They’re flocking to online review sites to choose which doctor to see, skipping hospital visits in favor of a health clinic in their local CVS, and aren’t afraid to ditch providers that don’t offer them an engaging experience.The superior customer service expectations of millennials, declines in hospital profitability, and threats from startup providers and retail pharmacies intensify the need for providers to revamp the patient experience. Providers’ current engagement capabilities are weak, and deficiencies around scheduling, appointment wait times, and billing are dragging on patient satisfaction, driving patients elsewhere and draining provider revenue.In The Healthcare Consumerization ReportBusiness Insider Intelligence explores the trends that are driving providers to revamp their care services. We then outline how patients’ expectations for transparency, convenience, and access are transforming the way they interact with providers across each stage of care. Finally, we detail strategies health systems and hospitals can implement to create a consumer-centric patient experience that fosters satisfaction, loyalty, and patient volume.The companies mentioned in this report are: 98point6, BayCare, Cleveland Clinic, CVS, Integris, Kaiser Permanente, Luma Health, New York-Presbyterian, One Medical, Publix, Target, Walgreens, Walmart, Yelp, and Zocdoc.Here are some of the key takeaways from the report:
  • The consumerization of healthcare is redefining how consumers engage with providers across each stage of care.
  • But the vast majority of healthcare providers haven’t sufficiently altered their services to align with current patient expectations. Only 8% of US hospitals and health systems demonstrate strong consumer-centric performance, per a 2018 Kaufman Hall survey.
  • Failure to react to patient preferences hurts provider organizations’ bottom lines. US hospital profit margins are already thinning, and an emerging reimbursement model that ties a portion of providers’ compensation to patient satisfaction means providers can’t afford to preserve the status quo.
  • Alternative players with consumer-focused healthcare services threaten to poach patients from traditional health systems. Tech-focused primary care startups, like One Medical and 98point6, and retail outlets, like Target, Walmart, and CVS, offer patients on-demand access to healthcare providers via mobile apps and convenient locations to receive healthcare services, drawing them away from incumbent health systems.
  • In order to retain patients — and keep them from straying to alternative care services — providers must transform their services with an emphasis on transparency, access, and ongoing engagement outside of the clinic.
  • Healthcare providers that tailor their services to the new healthcare consumer will be well positioned to see growth. Alternatively, businesses that don’t implement these changes could find themselves falling behind the rest of the industry or closing their doors for good.
In full, the report:
  • Details how patient behavior, preferences, and expectations have changed.
  • Outlines the demographic and industry trends that should add a sense of urgency for providers to revamp the patient experience.
  • Summarizes how the patient experience providers currently offer isn’t conducive to loyalty and is likely driving patients to nonhospital services.
  • Explains strategies health systems and hospitals can implement to create a consumer-centric patient experience that fosters satisfaction, loyalty, and patient volume.
  • Offers examples of provider organizations that have successfully adopted new strategies to encourage patient-doctor communication, improve satisfaction, and drive scheduling capacity.